Glycated hemoglobin HbA(1c) – a new risk marker for the outcome of cardiac surgery?

INTRODUCTION: About 30% of patients undergoing cardiac surgery are diabetic, and glycated hemoglobin (HbA(1c)) is a reliable marker for long-term glucose control. The aim of our study was to examine whether tight glucose control before a cardiac operation results in a better outcome of the surgical...

Descripción completa

Detalles Bibliográficos
Autores principales: Biskupski, Andrzej, Waligórski, Szymon, Kowalik, Bogdan, Żych, Andrzej, Sielicki, Piotr, Mirecki, Oktawiusz, Grudniewicz, Seweryn, Brykczyński, Mirosław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2014
Materias:
Cardiac Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283906/
https://www.ncbi.nlm.nih.gov/pubmed/26336385
http://dx.doi.org/10.5114/kitp.2014.41922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283906/
https://www.ncbi.nlm.nih.gov/pubmed/26336385
http://dx.doi.org/10.5114/kitp.2014.41922

Ejemplares similares